Aviva’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$488M Buy
1,126,326
+10,002
+0.9% +$3.04M 0.72% 22
2026
Q1
$239M Buy
1,116,324
+31,968
+3% +$7.15M 0.4% 38
2025
Q4
$186M Buy
1,084,356
+55,716
+5% +$8.67M 0.31% 56
2025
Q3
$138M Buy
1,028,640
+61,395
+6% +$6.5M 0.25% 76
2025
Q2
$94.2M Sell
967,245
-35,668
-4% -$2.83M 0.19% 112
2025
Q1
$72.9M Buy
1,002,913
+140,458
+16% +$11.1M 0.18% 127
2024
Q4
$62.3M Sell
862,455
-16,225
-2% -$1.23M 0.16% 129
2024
Q3
$71.7M Buy
878,680
+20,700
+2% +$1.8M 0.19% 115
2024
Q2
$91.4M Buy
857,980
+164,650
+24% +$15.8M 0.25% 73
2024
Q1
$67.4M Sell
693,330
-29,890
-4% -$2.63M 0.22% 86
2023
Q4
$56.6M Buy
723,220
+470
+0.1% +$32K 0.2% 97
2023
Q3
$45.3M Sell
722,750
-199,240
-22% -$13.1M 0.19% 100
2023
Q2
$59.3M Buy
921,990
+316,660
+52% +$17.8M 0.24% 78
2023
Q1
$32.1M Buy
605,330
+26,510
+5% +$1.3M 0.15% 190
2022
Q4
$24.3M Buy
578,820
+35,650
+7% +$1.49M 0.12% 237
2022
Q3
$19.9M Buy
543,170
+92,270
+20% +$4.11M 0.11% 240
2022
Q2
$19.2M Buy
450,900
+28,940
+7% +$1.38M 0.1% 267
2022
Q1
$22.7M Sell
421,960
-29,330
-6% -$1.71M 0.11% 203
2021
Q4
$32.5M Buy
451,290
+15,390
+4% +$965K 0.14% 151
2021
Q3
$24.8M Sell
435,900
-52,140
-11% -$3.17M 0.11% 189
2021
Q2
$31.8M Buy
488,040
+10,950
+2% +$691K 0.14% 151
2021
Q1
$28.4M Sell
477,090
-6,300
-1% -$343K 0.14% 151
2020
Q4
$22.8M Buy
483,390
+15,240
+3% +$641K 0.12% 170
2020
Q3
$15.5M Sell
468,150
-12,860
-3% -$443K 0.09% 196
2020
Q2
$15.6M Sell
481,010
-26,280
-5% -$717K 0.1% 185
2020
Q1
$12.2M Buy
507,290
+50
+0% +$1.44K 0.09% 192
2019
Q4
$14.8M Sell
507,240
-2,170
-0.4% -$57.6K 0.09% 200
2019
Q3
$11.8M Sell
509,410
-50,280
-9% -$1.06M 0.08% 230
2019
Q2
$10.5M Sell
559,690
-18,010
-3% -$342K 0.07% 260
2019
Q1
$10.3M Sell
577,700
-8,900
-2% -$149K 0.07% 271
2018
Q4
$7.99M Sell
586,600
-179,040
-23% -$2.57M 0.06% 304
2018
Q3
$11.6M Sell
765,640
-52,960
-6% -$904K 0.06% 299
2018
Q2
$14.2M Sell
818,600
-5,450
-0.7% -$105K 0.08% 242
2018
Q1
$16.7M Sell
824,050
-74,880
-8% -$1.48M 0.1% 218
2017
Q4
$16.5M Sell
898,930
-126,350
-12% -$2.48M 0.09% 235
2017
Q3
$19M Buy
1,025,280
+5,900
+0.6% +$95.7K 0.1% 224
2017
Q2
$14.4M Buy
1,019,380
+9,100
+0.9% +$133K 0.08% 279
2017
Q1
$13M Sell
1,010,280
-49,930
-5% -$587K 0.07% 285
2016
Q4
$11.2M Buy
1,060,210
+78,380
+8% +$796K 0.07% 312
2016
Q3
$9.3M Buy
981,830
+24,470
+3% +$223K 0.06% 358
2016
Q2
$8.05M Buy
957,360
+170,280
+22% +$1.37M 0.06% 355
2016
Q1
$6.5M Buy
787,080
+7,270
+0.9% +$52.9K 0.05% 405
2015
Q4
$6.19M Sell
779,810
-1,120
-0.1% -$8.42K 0.05% 413
2015
Q3
$5.1M Sell
780,930
-14,790
-2% -$108K 0.04% 456
2015
Q2
$6.47M Sell
795,720
-56,200
-7% -$441K 0.05% 417
2015
Q1
$5.98M Buy
851,920
+189,420
+29% +$1.5M 0.04% 484
2014
Q4
$5.26M Sell
662,500
-5,200
-0.8% -$40.3K 0.04% 455
2014
Q3
$4.99M Sell
667,700
-1,000
-0.1% -$7.13K 0.04% 488
2014
Q2
$4.52M Sell
668,700
-4,800
-0.7% -$28.7K 0.03% 514
2014
Q1
$3.7M Buy
673,500
+34,000
+5% +$181K 0.03% 550
2013
Q4
$3.48M Buy
639,500
+18,970
+3% +$99.8K 0.03% 562
2013
Q3
$3.18M Buy
620,530
+148,460
+31% +$726K 0.03% 562
2013
Q2
$2.09M Buy
+472,070
New +$2.13M 0.02% 596

Other funds holding LRCX

Aviva's LRCX Position: Q2 2026 in Review

Aviva increased its Lam Research (LRCX) stake by 0.9% in Q2 2026, buying an estimated $3.04M and bringing the position to 1,126,326 shares worth $488M. The position accounts for 0.72% of the portfolio, ranked #22.

Aviva first reported a position in LRCX in Q2 2013 and has held it in 53 quarters since. 3,110 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Aviva held 1,126,326 shares of Lam Research worth $488M as of Q2 2026.
  • Aviva bought 10,002 Lam Research shares in Q2 2026, an estimated $3.04M.
  • Lam Research made up 0.72% of Aviva's portfolio in Q2 2026, its #22 holding.
  • Aviva first reported a position in Lam Research in Q2 2013 and has held it in 53 quarters since.
  • 3,110 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.